D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FL
2326
PUT
DELISTED
Foot Locker
FL
| $2.34M | ﹤0.01% |
41,600
-23,200
| -36% | -$1.18M |
|
2327
CALL
KB Home
KBH
$3.54B
| $2.33M | ﹤0.01% |
50,000
-186,700
| -79% | -$7.71M |
|
2328
CALL
Ryman Hospitality Properties
RHP
$8.58B
| $2.33M | ﹤0.01% |
30,000
| – | – |
|
|
STEL
2329
DELISTED
Stellar Bancorp
STEL
| $2.32M | ﹤0.01% |
75,651
-3,793
| -5% | -$109K |
|
|
TSPQ.U
2330
DELISTED
TCW Special Purpose Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TSPQ.U
| $2.32M | ﹤0.01% |
+233,333
| New | +$2.33M |
|
2331
AtriCure
ATRC
$2.02B
| $2.31M | ﹤0.01% |
35,300
-95,773
| -73% | -$5.9M |
|
2332
PUT
Teva Pharmaceuticals
TEVA
$36.9B
| $2.31M | ﹤0.01% |
200,000
-1,014,800
| -84% | -$11.6M |
|
|
CCC
2333
CCC Intelligent Solutions
CCC
$3.59B
| $2.31M | ﹤0.01% |
+227,263
| New | +$2.76M |
|
2334
CALL
Snap-on
SNA
$21.7B
| $2.31M | ﹤0.01% |
+10,000
| New | +$1.97M |
|
|
CPE
2335
CALL
DELISTED
Callon Petroleum Company
CPE
| $2.31M | ﹤0.01% |
+59,800
| New | +$1.48M |
|
|
DHC
2336
Diversified Healthcare Trust
DHC
$2.28B
| $2.3M | ﹤0.01% |
+481,051
| New | +$2.21M |
|
2337
CALL
eBay
EBAY
$52.1B
| $2.3M | ﹤0.01% |
37,500
-491,100
| -93% | -$28.5M |
|
|
MSPR
2338
DELISTED
MSP Recovery Inc
MSPR
| $2.3M | ﹤0.01% |
53
+7
| +15% | +$313K |
|
2339
Vistra
VST
$50.1B
| $2.29M | ﹤0.01% |
129,699
-1,655,421
| -93% | -$32.9M |
|
|
CIVI
2340
DELISTED
Civitas Resources
CIVI
| $2.29M | ﹤0.01% |
63,994
+9,025
| +16% | +$254K |
|
2341
Molson Coors Class B
TAP
$7.97B
| $2.28M | ﹤0.01% |
44,631
-263,327
| -86% | -$12.8M |
|
2342
PUT
Itaú Unibanco
ITUB
$91.6B
| $2.28M | ﹤0.01% |
632,191
-164,920
| -21% | -$623K |
|
|
LEGOU
2343
DELISTED
Legato Merger Corp. Units
LEGOU
| $2.28M | ﹤0.01% |
+225,000
| New | +$2.33M |
|
2344
Valmont Industries
VMI
$9.33B
| $2.28M | ﹤0.01% |
9,578
-13,908
| -59% | -$3.08M |
|
|
K
2345
DELISTED
Kellanova
K
| $2.27M | ﹤0.01% |
38,161
-28,528
| -43% | -$1.6M |
|
|
SBNY
2346
PUT
DELISTED
Signature Bank
SBNY
| $2.26M | ﹤0.01% |
10,000
-15,000
| -60% | -$2.96M |
|
|
HIBB
2347
CALL
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.26M | ﹤0.01% |
+32,800
| New | +$2.02M |
|
2348
PUT
T-Mobile US
TMUS
$196B
| $2.25M | ﹤0.01% |
+18,000
| New | +$2.27M |
|
2349
Marvell Technology
MRVL
$157B
| $2.25M | ﹤0.01% |
45,998
-78,936
| -63% | -$3.87M |
|
2350
World Acceptance Corp
WRLD
$880M
| $2.25M | ﹤0.01% |
17,351
+5,779
| +50% | +$761K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.